Who Is The Biopharmaceutical Industry CEO Of The Year?

By Rob Wright, Chief Editor, Life Science Leader
Follow Me On Twitter @RfwrightLSL

I’ve been thinking, if you were going to name someone to be the biopharmaceutical industry CEO of the year, who would it be? But even more important than the who is the why. What criteria would you use? I’ve been looking through a bunch of articles that list top influencers for our industry, and the criterion for inclusion seems pretty subjective. There are media outlets that employ a variety of objective measures (i.e., company performance). And while perhaps better than a completely subjective approach, we all know that having great sales performance doesn’t necessarily make you a great leader. One of the best methodologies I have seen for naming a top CEO was done by the Harvard Business Review in 2015. It included financial data (weighted at 80 percent) and a measurement of a company’s environmental, social, and governance (ESG) performance (weighted at 20 percent).

Rather than copy this or any other methodology, I’d like to try a bit of a hybrid approach. But to get started I need your help. If you go to this link you will find a five-question survey that should take you less than two minutes to complete. The first step for us to get started is to create a pool of names of potential candidates with a rationale as to why.

I look forward to sharing the results in the coming months as we work toward determining who should be considered for the title — Biopharmaceutical CEO of the Year